Lactobionic acid
Star0
This drug entry is a stub and has not been fully annotated. It is scheduled to be annotated soon.
Identification
- Summary
Lactobionic acid is a component of a solution indicated in the preservation of organs from extraction to transplant.
- Generic Name
- Lactobionic acid
- DrugBank Accession Number
- DB16621
- Background
Not Available
- Type
- Small Molecule
- Groups
- Experimental
- Structure
- Weight
- Average: 358.296
Monoisotopic: 358.111126148 - Chemical Formula
- C12H22O12
- Synonyms
- Lactobionate
- External IDs
- 202-538-3
- EINECS 202-538-3
Pharmacology
- Indication
Not Available
Reduce drug development failure ratesBuild, train, & validate machine-learning modelswith evidence-based and structured datasets.Build, train, & validate predictive machine-learning models with structured datasets.- Contraindications & Blackbox Warnings
- Prevent Adverse Drug Events TodayTap into our Clinical API for life-saving information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.Avoid life-threatening adverse drug events with our Clinical API
- Pharmacodynamics
Not Available
- Mechanism of action
- Not Available
- Absorption
Not Available
- Volume of distribution
Not Available
- Protein binding
Not Available
- Metabolism
- Not Available
- Route of elimination
Not Available
- Half-life
Not Available
- Clearance
Not Available
- Adverse Effects
- Improve decision support & research outcomesWith structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates. View sample adverse effects data in our new Data Library!Improve decision support & research outcomes with our structured adverse effects data.
- Toxicity
Not Available
- Pathways
- Not Available
- Pharmacogenomic Effects/ADRs Browse all" title="About SNP Mediated Effects/ADRs" id="snp-actions-info" class="drug-info-popup" href="javascript:void(0);">
- Not Available
Interactions
- Drug Interactions Learn More" title="About Drug Interactions" id="structured-interactions-info" class="drug-info-popup" href="javascript:void(0);">
- This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.Not Available
- Food Interactions
- Not Available
Products
- Drug product information from 10+ global regionsOur datasets provide approved product information including:dosage, form, labeller, route of administration, and marketing period.Access drug product information from over 10 global regions.
- Mixture Products
Name Ingredients Dosage Route Labeller Marketing Start Marketing End Region Image Celsior Organkonservierungslösung Lactobionic acid (28.664 g/L) + Calcium chloride (0.037 g/L) + Glutamic acid (2.942 g/L) + Glutathione (0.921 g/L) + Histidine (4.65 g/L) + Magnesium chloride hexahydrate (2.642 g/L) + Mannitol (10.93 g/L) + Potassium chloride (1.118 g/L) + Sodium hydroxide (4 g/L) Solution Extracorporeal Institut Georges Lopez (Igl) 2012-02-09 Not applicable Austria
Categories
- Drug Categories
- Classification
- Not classified
- Affected organisms
- Not Available
Chemical Identifiers
- UNII
- 65R938S4DV
- CAS number
- 96-82-2
- InChI Key
- JYTUSYBCFIZPBE-AMTLMPIISA-N
- InChI
- InChI=1S/C12H22O12/c13-1-3(15)10(7(18)8(19)11(21)22)24-12-9(20)6(17)5(16)4(2-14)23-12/h3-10,12-20H,1-2H2,(H,21,22)/t3-,4-,5+,6+,7-,8-,9-,10-,12+/m1/s1
- IUPAC Name
- (2R,3R,4R,5R)-2,3,5,6-tetrahydroxy-4-{[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}hexanoic acid
- SMILES
- OC[C@@H](O)[C@@H](O[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O)[C@H](O)[C@@H](O)C(O)=O
References
- General References
- BASG: Celsior Organkonservierungslösung (Calcium Chloride, Glutamic Acid, Glutathione, Histidine, Lactobionic Acid, Magnesium Chloride, Mannitol, Potassium Chloride, Sodium Hydroxide) Extracorporeal Solution [Link]
- External Links
- ChemSpider
- 7040
- 1426413
- ChEBI
- 55481
- ChEMBL
- CHEMBL3039602
- ZINC
- ZINC000004215172
- Wikipedia
- Lactobionic_acid
Clinical Trials
- Clinical Trials Learn More" title="About Clinical Trials" id="clinical-trials-info" class="drug-info-popup" href="javascript:void(0);">
Phase Status Purpose Conditions Count 1 Completed Basic Science Type 1 Diabetes Mellitus 1
Pharmacoeconomics
- Manufacturers
- Not Available
- Packagers
- Not Available
- Dosage Forms
Form Route Strength Solution Extracorporeal - Prices
- Not Available
- Patents
- Not Available
Properties
- State
- Not Available
- Experimental Properties
- Not Available
- Predicted Properties
Property Value Source logP -5.2 Chemaxon pKa (Strongest Acidic) 3.26 Chemaxon pKa (Strongest Basic) -3.5 Chemaxon Physiological Charge -1 Chemaxon Hydrogen Acceptor Count 12 Chemaxon Hydrogen Donor Count 9 Chemaxon Polar Surface Area 217.6 Å2 Chemaxon Rotatable Bond Count 8 Chemaxon Refractivity 70.68 m3·mol-1 Chemaxon Polarizability 31.75 Å3 Chemaxon Number of Rings 1 Chemaxon Bioavailability 0 Chemaxon Rule of Five No Chemaxon Ghose Filter No Chemaxon Veber's Rule No Chemaxon MDDR-like Rule No Chemaxon - Predicted ADMET Features
- Not Available
Spectra
- Mass Spec (NIST)
- Not Available
- Spectra
Spectrum Spectrum Type Splash Key Predicted MS/MS Spectrum - 10V, Positive (Annotated) Predicted LC-MS/MS splash10-052f-0559000000-f9bf9a814d8e081cbca2 Predicted MS/MS Spectrum - 10V, Negative (Annotated) Predicted LC-MS/MS splash10-0ap0-4649000000-b9ba90b8c93d9fff905b Predicted MS/MS Spectrum - 20V, Positive (Annotated) Predicted LC-MS/MS splash10-03kl-6902000000-a6247412d35c51065a77 Predicted MS/MS Spectrum - 20V, Negative (Annotated) Predicted LC-MS/MS splash10-06vi-9662000000-7829ea740da37a599cd4 Predicted MS/MS Spectrum - 40V, Positive (Annotated) Predicted LC-MS/MS splash10-052s-9640000000-5a12ad0f1df35738fbad Predicted MS/MS Spectrum - 40V, Negative (Annotated) Predicted LC-MS/MS splash10-0a4u-9300000000-111ce03bf595e5759df2 Predicted 1H NMR Spectrum 1D NMR Not Applicable Predicted 13C NMR Spectrum 1D NMR Not Applicable - Chromatographic Properties
Collision Cross Sections (CCS)
Adduct CCS Value (Å2) Source type Source [M-H]- 175.7249841 predictedDarkChem Lite v0.1.0 [M-H]- 171.85931 predictedDeepCCS 1.0 (2019) [M+H]+ 175.1177841 predictedDarkChem Lite v0.1.0 [M+H]+ 173.58304 predictedDeepCCS 1.0 (2019) [M+Na]+ 175.0803841 predictedDarkChem Lite v0.1.0 [M+Na]+ 179.88338 predictedDeepCCS 1.0 (2019)
Drug created at February 24, 2021 21:24 / Updated at April 30, 2021 13:08